Latest Breaking News On - Keiretsu capital - Page 1 : comparemela.com

Healionics lands $5 5M to complete human trial of artificial blood vessel for dialysis patients

Healionics lands $5 5M to complete human trial of artificial blood vessel for dialysis patients
geekwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from geekwire.com Daily Mail and Mail on Sunday newspapers.

Mike connollyHealionic stargraftHealionics photoKeiretsu capital

FEMSelect Raises US$9M in Series B Financing

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

United statesTel avivRenee selmanEli lillyCenters for medicareHarvard collegeKeiretsu forumMedicaid servicesNew age venturesRobin hood venturesMid atlantic bio angelsKeiretsu forum mid atlanticKeiretsu capitalTranspacific ventureDebbie garnerWharton school

Women s Health Leader FEMSelect Secures US$9M Series B Financing

/PRNewswire/ FEMSelect, developer of EnPlace®, a minimally invasive, meshless approach to pelvic floor ligament fixation, announced today it has completed.

New yorkUnited statesFemselect enplacePrnewswire femselectCenters for medicareCommercialization of company enplaceInternational journal of gynecologyKeiretsu forumMedicaid servicesFunds will expand commercializationMinimally invasive prolapse repairNew age venturesRobin hood venturesMid atlantic bio angelsKeiretsu forum mid atlanticKeiretsu capital

Edible Insects Market 2021: Global Trends, Size, Segments And Growth Forecast To 2028 – Haber Radikal

Edible Insects Market 2021: Global Trends, Size, Segments And Growth Forecast To 2028 – Haber Radikal
haberradikal.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from haberradikal.com Daily Mail and Mail on Sunday newspapers.

Republic ofUnited statesHaocheng mealworm incJr unique foods ltdAgriculture organizationGlobal bugs asia co ltdFood groupThings bugsBeta hatch incEuropean food safety authorityInsect technology solutionsHolding ag switzerlandBusiness insightsInsects market sizeIndustry analysisInsect type

Healionics raises $4 7M to commercialize artificial blood vessel tech

Healionics raises $4.7M to commercialize artificial blood vessel tech May 13, 2021 at 10:58 am Healionics’ STARgraft vascular graft acts as an artificial blood vessel for dialysis patients. (Healionics Photo) New funding: Seattle-based medical technology company Healionics raised a $4.7 million round led by Keiretsu Capital to help commercialize its artificial blood vessel called STARgraft for patients who undergo dialysis treatment. Patients with failed kidneys can undergo dialysis several times per week to filter waste from the bloodstream. In administering the treatment, physicians often use a vascular graft to maintain access to the bloodstream, but current grafts often fail due to blockages, also known as vascular occlusion. STARgraft aims to provide high resistance to occlusion.

Healionic stargraftMike connollyHealionics photoKeiretsu capitalமைக் இணை